glp-1-based treatments approved for weight loss 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ BREAKING: The FDA has approved

Proinflammatory cytokines differentially influence adult hippocampal cell proliferation depending upon the route and chronicity of administration

Noom Med works by pairing users with a care team that may include doctors, nurse practitioners, dietitians and trained health coaches to help users safely meet weight or health goals

Blocking PINK1/Parkin-dependent mitophagy sensitizes multidrug-resistant liver cancer cells to B5G1, a new derivative of betulinic acid [319]

GLP-1 drugs (glucagon-like peptide-1 receptor agonists) are medications developed to treat both type 2 diabetes and obesity by correcting hormonal imbalance - stimulating insulin release and suppressing excess glucagon -to bring blood sugar back under control